$BCTX has initiated a research collaboration with http://Receptor.AI to design anti-cancer isoform-selective kinase inhibitors for multiple cancer indications. Check out the press release for all the details on this new pursuit!
https://globenewswire.com/news-release/2025/1...utics.html